Mylan CEO misled lawmakers about EpiPen profits—they’re 66% higher
Enlarge / Mylan Inc. CEO Heather Breschtestifies during a hearing before the House Oversight and Government Reform Committee September 21, 2016 on Capitol Hill in Washington, DC. Getty | Alex Wong reader comments 35 Share this story The EpiPen profit figures that Heather Bresch, CEO of EpiPen maker Mylan, Inc., proudly displayed on a giant chart to...
I regard the brain as a computer which will stop working when its component fail. There is no heaven or afterlife for broken-down computers. That is a fairy story for people afraid of the dark